概括
辅助特里莫克萨的预防可显著降低接受细胞毒性治疗的急性白血病患者的感染率. 这种口服抗生素有助于预防或延迟中性衰竭个体的感染.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有急性白血病的患者经常接受细胞毒药物,增加感染风险.
- 中性是化疗常见的副作用,使患者易受严重感染.
- 不能吸收的抗生素有时用于这些患者的感染预防.
研究的目的:
- 评价口服三醇在治疗细胞毒药的急性白血病患者中降低感染率方面的疗效.
- 为了比较接受co-trimoxazole和对照组的患者之间的感染率和抗生素需求.
主要方法:
- 一项随机试验,涉及30名接受细胞毒性治疗的急性白血病患者.
- 患者被分为两组:一组接受co-trimoxazole加非吸收抗生素,一组接受仅非吸收抗生素的对照组.
- 监测了感染率,需要额外的抗生素,中性质衰竭的持续时间和因感染而导致的死亡率.
主要成果:
- 与对照组 (94%) 相比,在co-trimoxazole组中,感染的患者显著减少 (57%).
- 接受co-trimoxazole的患者在严重中性质衰竭发作后需要更晚的静脉注射抗生素 (12天而不是2天).
- 两起因感染而导致的死亡仅发生在对照组中.
结论:
- 口服co-trimoxazole预防有效预防或延迟感染中性衰竭患者的急性白血病.
- 通过减少感染的发生率和延迟治疗感染的需要,co-trimoxazole 改善了结果.
- 这种预防策略对于管理免疫功能低下的癌症患者感染风险至关重要.
相关概念视频
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:26Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...